Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion: A Multicenter, Prospective, Open-Label, Endpoint-Blinded, Randomized Controlled Clinical Trial

NCT07390032 is registered in ClinicalTrials.gov with Feng Gao as lead sponsor.

NCT NCT07390032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07390032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion: A Multicenter, Prospective, Open-Label, Endpoint-Blinded, Randomized Controlled Clinical Trial
Lead sponsor
Feng Gao
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 31, 2029
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mild basilar artery occlusion, basilar artery occlusion, endovascular treatment